Tirzepatide can cost $500 to $1,900 a month without insurance. More affordable tirzepatide alternatives include semaglutide, ...
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists Compounded ...
As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...
Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. The U.S. Food and Drug Administration (FDA) recently ...
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...
Industry analysis examines published SURMOUNT clinical trial data, evolving FDA compounding guidance, and telehealth access ...
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to RegulationsSAN DIEGO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- As the post-holiday period brings ...
Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from Mounjaro. The Food and Drug Administration (FDA) does not regulate the ...
Share on Pinterest The FDA’s new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Images Provided by ...
Novo Nordisk’s CEO told CNN he is “alarmed” by the risks compounded versions of semaglutide — the active ingredient in the company’s diabetes drug Ozempic and weight loss drug Wegovy — are posing to ...
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or side effect disclosures. These compounded drugs, unlike generics, are not ...
Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know ...